Asthma Clinical Trials in Owensboro, Kentucky

4 studies are recruiting for asthma in Owensboro, Kentucky right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

    The primary purpose of this study is to evaluate the effects of Fluticasone Furoate (FF)/ Umeclidinium (UMEC)/ Vilanterol (VI) on lung function compared with FF/VI after 24 weeks of treatment.

    Stage
    Phase 3
    Ages
    12 to 17
    Site
    GSK Investigational Site, Owensboro, Kentucky
    Locations
    67 in total
    Run by
    GlaxoSmithKline

    See if you can join NCT05757102 on ClinicalTrials.gov

  2. A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

    The purpose of this study is to evaluate the effect of 2 different GP metered dose inhaler (MDI) doses relative to placebo MDI as add-on treatment to BFF MDI on lung function in participants 4 to less than 12 years of age with asthma.

    Stage
    Phase 2
    Ages
    4 to 11
    Site
    Research Site, Owensboro, Kentucky
    Locations
    43 in total
    Run by
    AstraZeneca

    See if you can join NCT07525375 on ClinicalTrials.gov

  3. A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

    The purpose of this study is to assess the safety and efficacy of brenipatide at different dose levels compared with placebo in participants with moderate-to-severe asthma. Study participation will last approximately 65 weeks, including screening, treatment, and follow-up periods.

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Allergy & Asthma Specialists, P.S.C., Owensboro, Kentucky
    Locations
    121 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT07219173 on ClinicalTrials.gov

  4. ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

    This study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and potential efficacy of ENV-294 in adults with moderate to severe asthma who are receiving background treatment with inhaled corticosteroids (ICS) and long-acting beta₂-agonists (LABA). Participants w…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Enveda Investigative Site, Owensboro, Kentucky
    Locations
    18 in total
    Run by
    Enveda Therapeutics

    See if you can join NCT07301255 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.